| Value | ₹0.06 Cr |
|---|
BSE filing, NSE: MUTHOOTFIN. Summary written from the filing by ALFA Finder's alert engine.
Muthoot Finance Ltd: key numbers
- Share price
- ₹2,514.70
- Market cap
- ₹1,00,957 Cr
- Revenue (annual)
- ₹31,209 Cr
- Net profit (annual)
- ₹10,590 Cr
- P/E (TTM)
- 8.3×Sector 19.1×
- Promoter holding
- 73.35%+0.00% QoQ
- FII holding
- 9.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Muthoot Finance Ltd
All →Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Muthoot Finance Debt & Borrowing: ₹2.32 Cr
Muthoot Finance paid monthly interest of Rs.2.32 Crore across nine secured NCD series on November 2, 2026. The payments were made one day after the November 1 due date.
- Value
- ₹2.32 Cr
Muthoot Finance Debt & Borrowing
Muthoot Finance submitted its September 30, 2026 security cover statement for secured NCDs. The auditors certify the cover is adequate under the trust deeds.
Muthoot Finance Investor Presentation: Key Takeaways
Q2 FY27/H1 FY27: consolidated PAT ₹6,103 Cr (+39%), AUM ₹2,09,317 Cr (+42%). Gold loan dominant; subsidiaries scaling, Muthoot Money AUM +99%.
Muthoot Finance Results Update
Muthoot Finance's consolidated profit after tax rose 39% year-on-year to ₹6,103 Crore for the half year. Consolidated loan AUM grew 42% to ₹2,09,317 Crore.
Muthoot Finance Q2 FY27 Results: Net Profit ₹3,278 Cr, Up 35.9% YoY
Muthoot Finance Ltd reported revenue from operations of ₹9,998 Cr (+37.3% YoY) and net profit of ₹3,278 Cr (+35.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3,278 Cr · +35.9% YoY
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.
Technocraft Ventures Legal & Regulatory
Technocraft's GST appeal against a ₹3.44 crore demand was allowed by the Appellate Authority. The company gains relief from the demand, penalty and interest.
- Value
- ₹3.44 Cr